T. Rowe Price Associates’s Accelerate Diagnostics AXDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-6,390
| Closed | -$52K | – | 2890 |
|
|
2023
Q2 | $52K | Hold |
6,390
| – | – | ﹤0.01% | 2792 |
|
|
2023
Q1 | $45K | Sell |
6,390
-2,638
| -29% | -$18.6K | ﹤0.01% | 2800 |
|
|
2022
Q4 | $64K | Hold |
9,028
| – | – | ﹤0.01% | 2780 |
|
|
2022
Q3 | $138K | Hold |
9,028
| – | – | ﹤0.01% | 2649 |
|
|
2022
Q2 | $90K | Buy |
9,028
+4,573
| +103% | +$45.6K | ﹤0.01% | 2768 |
|
|
2022
Q1 | $64K | Buy |
4,455
+2,620
| +143% | +$37.6K | ﹤0.01% | 2891 |
|
|
2021
Q4 | $96K | Buy |
1,835
+320
| +21% | +$16.7K | ﹤0.01% | 2878 |
|
|
2021
Q3 | $88K | Buy |
1,515
+30
| +2% | +$1.74K | ﹤0.01% | 2855 |
|
|
2021
Q2 | $120K | Buy |
+1,485
| New | +$120K | ﹤0.01% | 2812 |
|
|
2018
Q4 | – | Sell |
-958
| Closed | -$220K | – | 2550 |
|
|
2018
Q3 | $220K | Buy |
958
+36
| +4% | +$8.27K | ﹤0.01% | 2428 |
|
|
2018
Q2 | $206K | Buy |
922
+3
| +0.3% | +$670 | ﹤0.01% | 2439 |
|
|
2018
Q1 | $210K | Buy |
919
+8
| +0.9% | +$1.83K | ﹤0.01% | 2386 |
|
|
2017
Q4 | $239K | Sell |
911
-46
| -5% | -$12.1K | ﹤0.01% | 2343 |
|
|
2017
Q3 | $215K | Buy |
+957
| New | +$215K | ﹤0.01% | 2374 |
|